Tear Lipid Layer Thickness With Emollient Eye Drops

NCT03380624 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: Refresh Optive
DRUG: Refresh Optive MEGA-3

Sponsor

Ohio State University

Collaborators

[object Object]